Plasma IL-12/IFN-γ axis predicts cognitive trajectories in cognitively unimpaired older adults
- PMID: 34160128
- PMCID: PMC8695625
- DOI: 10.1002/alz.12399
Plasma IL-12/IFN-γ axis predicts cognitive trajectories in cognitively unimpaired older adults
Abstract
Introduction: Immune dysregulation is implicated in neurodegeneration and altered cytokine levels are seen in people with dementia. However, whether cytokine levels are predictive of cognitive decline in cognitively unimpaired (CU) elderly, especially in the setting of elevated amyloid beta (Aβ), remains unclear.
Methods: We measured nine cytokines in the baseline plasma of 298 longitudinally followed CU elderly and assessed whether these measures were associated with cognitive decline, alone or synergistically with Aβ. We next examined associations between cytokine levels and neuroimaging biomarkers of Aβ/tau/neurodegeneration.
Results: Higher IL-12p70 was associated with slower cognitive decline in the setting of higher Aβ (false discovery rate [FDR] = 0.0023), whereas higher IFN-γ was associated with slower cognitive decline independent of Aβ (FDR = 0.013). Higher IL-12p70 was associated with less tau and neurodegeneration in participants with higher Aβ.
Discussion: Immune dysregulation is implicated in early-stage cognitive decline, and greater IL-12/IFN-γ axis activation may be protective against cognitive decline and early-stage AD progression.
Keywords: Alzheimer's disease; IFN-γ; IL-12; biomarker; cognitive decline; neuroimaging; preclinical Alzheimer's disease.
© 2021 the Alzheimer's Association.
Conflict of interest statement
Figures
Similar articles
-
Tau Mediates Synergistic Influence of Vascular Risk and Aβ on Cognitive Decline.Ann Neurol. 2022 Nov;92(5):745-755. doi: 10.1002/ana.26460. Epub 2022 Aug 13. Ann Neurol. 2022. PMID: 35880989 Free PMC article.
-
Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.J Neurosci. 2019 Sep 11;39(37):7428-7437. doi: 10.1523/JNEUROSCI.1056-19.2019. Epub 2019 Jul 26. J Neurosci. 2019. PMID: 31350262 Free PMC article.
-
Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.JAMA Neurol. 2019 Jul 1;76(7):791-799. doi: 10.1001/jamaneurol.2019.0765. JAMA Neurol. 2019. PMID: 31009028 Free PMC article.
-
Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.Brain. 2020 Dec 1;143(12):3793-3804. doi: 10.1093/brain/awaa342. Brain. 2020. PMID: 33210117 Free PMC article.
-
Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative.Alzheimers Dement. 2019 Jan;15(1):106-152. doi: 10.1016/j.jalz.2018.08.005. Epub 2018 Oct 13. Alzheimers Dement. 2019. PMID: 30321505 Review.
Cited by
-
Targeting Myeloperoxidase to Reduce Neuroinflammation in X-Linked Dystonia Parkinsonism.CNS Neurosci Ther. 2024 Nov;30(11):e70109. doi: 10.1111/cns.70109. CNS Neurosci Ther. 2024. PMID: 39500625 Free PMC article.
-
Inflammaging and Brain Aging.Int J Mol Sci. 2024 Sep 30;25(19):10535. doi: 10.3390/ijms251910535. Int J Mol Sci. 2024. PMID: 39408862 Free PMC article. Review.
-
Cytokine dysregulation in amnestic mild cognitive impairment.Sci Rep. 2024 Sep 28;14(1):22486. doi: 10.1038/s41598-024-73099-z. Sci Rep. 2024. PMID: 39341896 Free PMC article.
-
Profiling migration of human monocytes in response to chemotactic and barotactic guidance cues.Cell Rep Methods. 2024 Sep 16;4(9):100846. doi: 10.1016/j.crmeth.2024.100846. Epub 2024 Sep 5. Cell Rep Methods. 2024. PMID: 39241776 Free PMC article.
-
Proteomics identifies potential immunological drivers of postinfection brain atrophy and cognitive decline.Nat Aging. 2024 Sep;4(9):1263-1278. doi: 10.1038/s43587-024-00682-4. Epub 2024 Aug 14. Nat Aging. 2024. PMID: 39143319 Free PMC article.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
